EP303/#705 Efficacy and safety of anlotinib plus albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or peritoneal carcinoma: a prospective phase II clinical trial

Abstract

ObjectivesWe examined the efficacy and safety of combining anlotinib with albumin-bound)paclitaxel (ab-paclitaxel) in patients with recurrent,platinum-resistant ovarian or peritoneal carcinoma.MethodsIn this study,44 patients progressing within 6 months after prior platinum-based...